celecoxib has been researched along with B16 Melanoma in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Herein we analyzed the effect of cyclooxygenase-2 (COX-2) inhibitor celecoxib in a model of generalized BM dissemination of left cardiac ventricle-injected B16 melanoma (B16M) cells into healthy and bacterial endotoxin lipopolysaccharide (LPS)-pretreated mice to induce inflammation." | 3.77 | Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2. ( Carrascal, T; Crende, O; Hernández, JJ; Mendoza, L; Salado, C; Valcárcel, M; Vidal-Vanaclocha, F, 2011) |
| "Treatment with celecoxib had effects on inflammation response and reduced cancer metastasis." | 1.39 | Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis. ( Bi, Y; Han, M; Jia, J; Jiang, M; Liu, Q; Xu, J; Xu, X, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, X | 1 |
| Zhang, H | 1 |
| Li, X | 1 |
| Chen, G | 1 |
| Li, QS | 1 |
| Luo, Y | 1 |
| Ruan, BF | 1 |
| Chen, XW | 1 |
| Zhu, HL | 1 |
| Zhou, P | 1 |
| Qin, J | 1 |
| Li, Y | 1 |
| Li, G | 1 |
| Wang, Y | 1 |
| Zhang, N | 1 |
| Chen, P | 1 |
| Li, C | 1 |
| Pritchard, R | 1 |
| Rodríguez-Enríquez, S | 1 |
| Pacheco-Velázquez, SC | 1 |
| Bortnik, V | 1 |
| Moreno-Sánchez, R | 1 |
| Ralph, S | 1 |
| Ahmed, KS | 1 |
| Shan, X | 1 |
| Mao, J | 1 |
| Qiu, L | 1 |
| Chen, J | 1 |
| Valcárcel, M | 1 |
| Mendoza, L | 1 |
| Hernández, JJ | 1 |
| Carrascal, T | 1 |
| Salado, C | 1 |
| Crende, O | 1 |
| Vidal-Vanaclocha, F | 1 |
| Han, M | 1 |
| Xu, J | 1 |
| Bi, Y | 1 |
| Jiang, M | 1 |
| Xu, X | 1 |
| Liu, Q | 1 |
| Jia, J | 1 |
6 other studies available for celecoxib and B16 Melanoma
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Cyclooxygenase 2; Cyclooxy | 2011 |
Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis.
Topics: Amidines; Animals; Benzene Derivatives; Cdh1 Proteins; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 | 2017 |
Celecoxib inhibits mitochondrial O
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Celecoxib; Cell | 2018 |
Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Celecoxib; Cell Death; Doxorubicin; Drug | 2019 |
Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.
Topics: Animals; Blotting, Western; Bone Marrow; Bone Marrow Neoplasms; Celecoxib; Cell Adhesion; Cell Line, | 2011 |
Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis.
Topics: Animals; Biomarkers, Tumor; Celecoxib; Cyclooxygenase 2 Inhibitors; Cytokines; Female; Inflammation; | 2013 |